WALDENSTROM MACROGLOBULINEMIA
Clinical trials for WALDENSTROM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lymphoma patients who Can't tolerate standard drugs
Disease control CompletedThis study tested a drug called zanubrutinib for people with several types of B-cell lymphoma who had to stop their previous treatments due to bad side effects. The main goal was to see if zanubrutinib caused fewer or less severe side effects for these patients. Researchers also …
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New pill tested for Tough-to-Treat blood cancers
Disease control CompletedThis study tested a new oral medication called pirtobrutinib for people with chronic lymphocytic leukemia or other B-cell lymphomas that had stopped responding to standard treatments. The main goals were to find a safe and effective dose and to see if the drug could shrink tumors…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for Tough-to-Treat blood cancer? scientists test promising drug
Disease control CompletedThis study aimed to find a safe and effective dose of the drug lenalidomide for adults with Waldenstrom Macroglobulinemia, a rare and incurable blood cancer, whose disease had returned or was not responding to other therapies. It involved a small group of 17 participants to first…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill tested for Tough-to-Treat blood cancers
Disease control CompletedThis first-in-human study tested a new oral drug called BR101801 in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early s…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Study tests if blood cancer patients can build COVID-19 protection
Knowledge-focused CompletedThis study measured how well people with multiple myeloma or Waldenstrom's macroglobulinemia respond to COVID-19 vaccines. Researchers tested 146 participants to see if their weakened immune systems could produce protective antibodies after vaccination. The goal was to understand…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Could a simple blood test replace painful bone marrow biopsies?
Knowledge-focused CompletedThis study aimed to see if blood and urine tests could be as good as bone marrow biopsies for diagnosing and monitoring a rare blood cancer called Waldenström's macroglobulinemia. Researchers compared test results from 300 patients to find less invasive ways to track the disease.…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC